Pharmacists in Glen Carbon, Illinois


13 Pharmacists found in Glen Carbon
female pharmacist

Mrs. Cheri Trauernicht, RPH


Pharmacist
400 Junction Dr, Glen Carbon, IL 62034
619-659-1395    

male pharmacist

Eric C Hess


Pharmacist
400 Junction Dr, Glen Carbon, IL 62034
618-659-1395    

male pharmacist

Eric Joseph Bomba


Pharmacist
5 Illini Dr, Glen Carbon, IL 62034
618-359-7339    



male pharmacist

Dr. Gregory Anthony Cochran, PHARM. D.


Pharmacist
5 Illini Dr, Glen Carbon, IL 62034
618-659-7339     618-659-7340

female pharmacist

Hannah Wieland


Pharmacist
5 Illini Dr, Glen Carbon, IL 62034
618-659-7339     618-659-7340

female pharmacist

Dr. Heidi Marie Trackwell, PHARM.D.


Pharmacist
2 Cottonwood Rd, Glen Carbon, IL 62034
618-288-4684     618-288-4689

male pharmacist

James Allan Staley, RPH.


Pharmacist
#2 Cottonwood Rd, Glen Carbon, IL 62034
618-288-4684    

female pharmacist

Kelli Williams


Pharmacist
400 Junction Dr, Glen Carbon, IL 62034
618-659-1395    

male pharmacist

Dr. Kevin Michael Luitjohan


Pharmacist
400 Junction Dr, Glen Carbon, IL 62034
618-659-1395    

male pharmacist

Mr. Mark L Mcaninch, RPH


Pharmacist
2 Cottonwood Rd, Glen Carbon, IL 62034
618-288-4684    

female pharmacist

Miss Mary Margaret Worster


Pharmacist
2 Cottonwood Rd, Glen Carbon, IL 62034
618-288-4684     618-288-4689

female pharmacist

Natalie J Parr


Pharmacist
105 Oakshire Dr E, Glen Carbon, IL 62034
618-593-9526    

female pharmacist

Rebecca Franke Philipps, PHARM.D.


Pharmacist
2 Lantern Ct, Glen Carbon, IL 62034
618-288-0620    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.